Search company, investor...
Search
Sesame Enable company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sesame-enable.com

About Sesame Enable

Sesame-Enables vision is to allow and promote independent living for the disabled. We developed a technology that enables hands-free operation of touch devices, allowing to operate a device using the on-board camera. We support Android and IOS devices. The company was jointly founded by disabled people and computer vision technology experts.We at Sesame are dedicated to enabling access to mobile devices to audiences who cannot operate the devices with their hands. We offer an inclusive technology that helps people use devices which are currently out of their reach. Furthermore, the technology could also cater to more common uses, such as reading on the bus, browsing recipes while cooking, reading in bed, and more.

Sesame Enable Headquarters Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Sesame Enable Patents

Sesame Enable has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/20/2015

9/12/2017

VoIP protocols, Network protocols, Netbooks, Pointing devices, Servers (computing)

Grant

Application Date

10/20/2015

Grant Date

9/12/2017

Title

Related Topics

VoIP protocols, Network protocols, Netbooks, Pointing devices, Servers (computing)

Status

Grant

Latest Sesame Enable News

Israeli Touch-Free Phone Creator Sesame Enable Opens US HQ

Nov 14, 2017

November 14, 2017 | The Israeli tech company Sesame Enable , the creator of the first hands-free smartphone and a developer of hands-free control technologies for mobile devices, has opened its first US headquarters in Bethesda, Maryland. The Hadera-based company was founded in 2012, developing its Open Sesame technology which enables users to operate smartphones through head movements and voice commands. The touch-free smartphone is primarily aimed at disabled users and those who cannot use their hands. It was developed by tech entrepreneur Oded Ben Dov and former electrical engineer Giora Livne , who became a quadriplegic following a serious accident over a decade ago. The technology is used in the Maryland Accessible Telecommunications (MAT) program which gives communications devices to disabled citizens, according to a report in the Washington Business Journal. Executives from Sesame Enable met Maryland Governor Larry Hogan during a trade mission to Israel in 2016. “Governor Hogan has been an active supporter of Sesame Enable for the past year as we searched for a US headquarters that would align with our vision of supporting people with physical challenges,” said Sesame Enable CEO and co-founder Oded Ben Dov, in a statement released by the governor’s office. “We chose Maryland because of the backing we have received from the state subsidy program, and Bethesda’s proximity to health institutions, including those focusing on veterans. In addition, we are now close to Washington, DC, where we know we’ll have opportunity to influence change needed to make our technology readily available to all Americans who can benefit from it.” November 14, 2017 | Fifteen Israeli ICT and Life Science companies were selected to present their technologies to the Chinese market at the annual Israeli roadshow in China, an event organized by the Israel Innovation Authority in cooperation with the Chinese Ministry of Science and Technology. While more than 160 Israeli companies signed up, only 15 were selected out of 40 by a Chinese investors’ delegation in a preliminary pitching event held in Israel in July 2017 by the Israeli Innovation Authority. During the roadshow, Israeli companies visited Shanghai, Changzhou and Beijing and held more than 100 B2B meetings to promote cooperation. The companies also participated in pitching events in Changzhou and Beijing, presenting their products and technologies to dozens of investors, investment groups and companies like Fuson, PingAn Ventures, Go Capital, and San Power. The pitching events were organized as competitions and three Israeli companies won modest monetary awards in each city. The winning companies in Changzhou were Life Science companies Brainsway , Vectorious Medical Technologies , and OrthoDrill Medical . The winning companies in Beijing were ICT companies Myndlift , CellO-Photonics, and Brainster . November 13, 2017 | Israeli regenerative medicine company Collplant has raised about $7.4 million in private placement due to a number of filings submitted by the company to the Tel Aviv Stock Exchange over the past three months, according to a report in Calcalist. In November, the Ness Ziona-based company announced a private placement agreement with Ami Sagi, father of Israeli-born businessman Teddy Sagi. The agreement was worth $1.05 million. They also announced an agreement with Israeli investment company Meitav Dash Investments for $1.34 million. In September, the company had a private investment agreement of $5 million signed with Alpha Capital Anstalt of Lichtenstein. In June of this year, Collplant filed a U.S. patent application for a collegen-based bio-ink for “3D printing of tissues and organs.” The company wants to establish its ink in the market and is negotiating with companies in organ printing. Collplant develops medical treatments using plant-based collagen. Human collagen can be harvested from a plant that is created with a combination of human genes and tobacco plant DNA. The company was founded in 2004 by Oded Shosheyov. November 13, 2017 | Researchers at Haifa’s Rambam Medical Center and the Technion-Israel Institute of Technology have decoded a mechanism that leads to why some patients of thyroid cancer appear to be unaffected by iodine treatment. Iodine is a standard treatment for the disease, but is causing a resistance of thyroid tumors. According to a report in the Jerusalem Post, some patients are developing a distant metastases or local recurrence that is resistant to iodine therapy, causing low survival rates. Iodine treatment is based on partial or full removal of the gland in the front part of the neck, through surgery, with a supplement of radioactive iodine if necessary. Thyroid cells transfer iodine through specific channels that allow the radioactive iodine to enter the cancer cells in the body and destroy them without harming other tissues.The research was published in the Journal of the National Cancer Institute. This research was published in the Journal of the National Cancer Institute (JNCI) and offers hope for more successful treatments in the future. November 12, 2017 | Israeli pharmaceutical company Nextar Chempharma Solutions will set up an incubator and development center for medical cannabis products, accepting at least six companies per year for the project with initial investment of between $100,000 and $400,000, according to a report in Globes . Nextar will provide a variety of services to the participating companies, “including laboratory and analytic testing, business development, and clinical trial management services.” Nextar will also provide cannabis development services to external companies and will independently develop its own cannabis products, according to the report which added that the company has signed an initial cooperation deal Australia’s Budding Tech, an organization that works in the medical cannabis sector. Nextar is excepted to invest $5 million in the venture. November 12, 2017 | Israel and India inaugurated a beekeeping development center over the weekend in the city of Ramnagar in the province of Harnaya in northern India. The center is officially called the Center of Excellence for Integrated Beekeeping Development, and is one of 18 centers of excellence set up through the Indo-Israeli Agricultural Project (IIAP), a collaboration project between the Indian Federal Government, Indian State Governments and Israel’s Agency for International Development Cooperation – MASHAV, the Israeli Embassy in Israel said in a statement. The embassy said the Beekeeping center in Ramnagar was the first of its kind between India and Israel, and will address a number of issues like “Queen Rearing, Quality Control Labs, Enhanced Production, Honey Production Value Chain, [and] Pollination.” The IIAP is active in nine states across India, and is set to include seven more states in the next phase. The Israeli ambassador to India, Daniel Carmon, said in a tweet on Friday that a dairy farming center of excellence would soon be inaugurated but did not specify where. “Centers of Excellence are an integral part of India and Israel’s growing partnership. Haryana is one of the first to implement this tool for its farmers, and has more IIAP centers than any other state. I hope to see more states open IIAP centers across India, and that the private sector too joins us in the endeavor to bring advanced agro-technology to Indian farmers,” Carmon said in a statement.What a grand inauguration of the @MASHAVisrael #MIDH #Beekeeping #CenterofExcellence in #Ramnagar , #Haryana with the August presence of CM @mlkhattar @cmohry #agriculture Minister @OPDhankar and many,many farmers and beekeepers. Congratulations! @IsraelinIndia pic.twitter.com/KX80YGPcsx — Daniel Carmon

Sesame Enable Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sesame Enable Rank

    Discover the right solution for your team

    The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

    Request a demo

    CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.